Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer

Research To Practice | Oncology Videos

Featuring perspectives from Dr Matthew Gubens, including the following topics:

• Introduction: Risk of Autoimmune Toxicity with Checkpoint Inhibitors (0:00)
• Immunotherapy in the Neoadjuvant/Adjuvant Setting (7:33)
• Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (15:45)
• First-Line Immunotherapy for Metastatic NSCLC (24:04)
• Novel Agents and Strategies (30:39)
• Immunotherapy for NSCLC with a Targetable Mutation (41:34)
• Small Cell Lung Cancer (47:06)

CME information and select publications